Biostatistical considerations in pharmac
โ
Robert T. O'Neill
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 72 KB
๐ 1 views
This paper deals with a conceptual discussion of a variety of statistical concepts, methods and strategies that are relevant to the quantitative assessment of risk derived from safety data collected during the pre-and post-marketing phase of a new drug's life cycle. A call is made for the use of mor